Stocktoria
Keros Therapeutics, Inc. KROS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-04-08
Keros Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 2,513,244 | $114.9M | 6.64% |
| AQR CAPITAL MANAGEMENT LLC | 967,859 | $10.4M | 2.56% |
| CITADEL ADVISORS LLC | 410,498 | $4.4M | 1.08% |
| RENAISSANCE TECHNOLOGIES LLC | 359,086 | $3.8M | 0.95% |
| D. E. Shaw & Co., Inc. | 267,460 | $2.9M | 0.71% |
| TWO SIGMA INVESTMENTS, LP | 246,649 | $2.6M | 0.65% |
| MILLENNIUM MANAGEMENT LLC | 184,822 | $2.0M | 0.49% |
| Point72 Asset Management, L.P. | 10,393 | $111,205 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.